Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-02-03 @ 4:12 AM
Study NCT ID:
NCT03481556
Status:
TERMINATED
Last Update Posted:
2022-12-19
First Post:
2018-03-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM
Sponsor:
Oncopeptides AB
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords: